A Single-center, Randomized, Blinded, Different Doses, Positive Control, Phase II to Evaluate the Inactivated EV71 Vaccine Immunogenicity and Safety in Healthy Volunteers Aged 6 to 71 Months
Latest Information Update: 07 Jul 2023
At a glance
- Drugs Enterovirus A vaccine (Primary)
- Indications Enterovirus A infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Beijing Zhifei Lvzhu Biopharmaceutical
Most Recent Events
- 29 Jun 2023 New trial record